Wikidata

(Q51017581)

English

Bortezomib ADDED to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials Group.

scientific article published in August 2011

In more languages
default values for all languages
No label defined

No description defined

Statements

title
Bortezomib ADDED to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials Group (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21810681
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21810681%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q51017581&oldid=1521634676"